TriSalus Life Sciences, Inc.
TLSI
$4.20
$0.020.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.38M | -10.11M | -2.39M | -4.33M | -13.21M |
| Total Depreciation and Amortization | 172.00K | 193.00K | 169.00K | 194.00K | 175.00K |
| Total Amortization of Deferred Charges | 235.00K | 178.00K | 167.00K | 267.00K | -- |
| Total Other Non-Cash Items | 3.87M | 3.56M | -5.64M | -3.17M | 2.65M |
| Change in Net Operating Assets | 1.60M | 467.00K | -3.15M | -6.38M | -483.00K |
| Cash from Operations | -4.50M | -5.71M | -10.85M | -13.42M | -10.87M |
| Capital Expenditure | -754.00K | -50.00K | -169.00K | -60.00K | -66.00K |
| Sale of Property, Plant, and Equipment | 40.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -714.00K | -50.00K | -169.00K | -60.00K | -66.00K |
| Total Debt Issued | 10.00M | 0.00 | 0.00 | 25.00M | -- |
| Total Debt Repaid | -71.00K | -19.00K | -22.00K | -21.00K | -22.00K |
| Issuance of Common Stock | 279.00K | 3.01M | 5.85M | 3.61M | 3.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -520.00K | 0.00 | 0.00 | -2.59M | -- |
| Cash from Financing | 9.69M | 2.99M | 5.82M | 25.99M | 3.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.48M | -2.76M | -5.19M | 12.51M | -7.81M |